Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00NVC
|
||||
Former ID |
DNC004042
|
||||
Drug Name |
Z-Ala-Leu-Nal-Agly-Ile-Val-OMe
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526417] | ||
Structure |
Download2D MOL |
||||
Formula |
C43H59N7O9
|
||||
Canonical SMILES |
CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CC=CC2<br />=CC=CC=C21)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC3=CC=CC=C3
|
||||
InChI |
1S/C43H59N7O9/c1-9-27(6)36(40(54)47-35(26(4)5)41(55)58-8)48-42(56)50-49-39(53)34(23-31-20-15-19-30-18-13-14-21-32(30)31)46-38(52)33(22-25(2)3)45-37(51)28(7)44-43(57)59-24-29-16-11-10-12-17-29/h10-21,25-28,33-36H,9,22-24H2,1-8H3,(H,44,57)(H,45,51)(H,46,52)(H,47,54)(H,49,53)(H2,48,50,56)
|
||||
InChIKey |
KMJURIDKPLGXEZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cathepsin B | Target Info | Inhibitor | [526417] | |
Cathepsin K | Target Info | Inhibitor | [526417] | ||
Reactome | Collagen degradation | ||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
MHC class II antigen presentation | |||||
WikiPathways | RANKL/RANK Signaling Pathway | ||||
Osteoclast Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.